NO993171L - Substituerte propionylderivater - Google Patents
Substituerte propionylderivaterInfo
- Publication number
- NO993171L NO993171L NO993171A NO993171A NO993171L NO 993171 L NO993171 L NO 993171L NO 993171 A NO993171 A NO 993171A NO 993171 A NO993171 A NO 993171A NO 993171 L NO993171 L NO 993171L
- Authority
- NO
- Norway
- Prior art keywords
- group
- single bond
- divalent
- bond
- esterified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse angår en forbindelse representert ved den følgende formel (1):. [hvor, Xrepresenterer en karboksylgruppe som kan være forestret eller lignende gruppe; Yrepresenterer en enkeltbinding, -O- eller -N(R)-; minst én av A, A2 og Aer en gruppe representert ved den følgende formel (2):{hvor,.Rrepresenterer en divalent C.,hydrokarbongruppe, R3 representerer en enkeltbinding eller en divalent C,.,hydrokarbongruppe, a' og a2 individuelt representerer en enkeltbinding, -S-, -SO-, -S0-, -S0NH-, -O-, -N(R)-, -CO(R)-, -C(=0)- eller -Si(R')(R)- og -► betyr binding med Q\ Qeller, de gjenværende én eller to av A, Aog A3 er like eller forskjellige og representerer hver uavhengig en gruppe representert ved den følgende formel (3):{hvor, R" og Rindividuelt representerer en enkeltbinding eller en divalent C,.,hydrokarbongruppe, aog aindividuelt representerer en enkeltbinding, -S-, -SO-, -S0-, -S0NH-, -O-, -N(R)-, -CON(R)-, -C(=0)- eller -SI(R)(R)- og betyr binding med Q\ Qeller Q},;. minst én av Q, Qog Qrepresenterer en cyklisk hydrokarbongruppe eller heterocyklisk gruppe og de gjenværende én eller to av Q\ Qog Qindividuelt representerer et hydrogenatom, en karboksylgruppe som kan være forestret, en hydrokarbongruppe eller en heterocyklisk gruppe] eller et salt derav; og et farmasøytisk preparat omfattende disse som aktiv bestanddel. Forbindelsene har sterk skvalen-syntetase-hemmende virkning og er derfor nyttige som farmasøytiske preparater for behandling/forebyggelse av hyperkolesterolemi, hyperlipemi eller arteriosklerose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35067396 | 1996-12-27 | ||
PCT/JP1997/004879 WO1998029380A1 (fr) | 1996-12-27 | 1997-12-26 | Derives de propionyle substitues |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993171D0 NO993171D0 (no) | 1999-06-25 |
NO993171L true NO993171L (no) | 1999-08-25 |
Family
ID=18412084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993171A NO993171L (no) | 1996-12-27 | 1999-06-25 | Substituerte propionylderivater |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0949238A1 (no) |
AU (1) | AU5341198A (no) |
BR (1) | BR9714087A (no) |
CA (1) | CA2275603A1 (no) |
ID (1) | ID22281A (no) |
NO (1) | NO993171L (no) |
WO (1) | WO1998029380A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR029304A1 (es) * | 1998-06-26 | 2003-06-25 | Daiichi Seiyaku Co | DERIVADOS DE PROPIONILO SUSTITUIDOS, PRODUCTO FARMACEUTICO, USO PARA LA FABRICACION DE UNA COMPOSICION FARMACEUTICA PARA LA PREVENCION Y/O TRATAMIENTO DE HIPERCOLESTEROLEMIA, HIPERLIPEMIA O ARTERIOESCLEROSIS, COMPOSICIoN FARMACÉUTICA Y COMPUESTOS INTERMEDIARIOS |
US6521658B1 (en) | 1999-05-28 | 2003-02-18 | Abbott Laboratories | Cell proliferation inhibitors |
CO5170498A1 (es) * | 1999-05-28 | 2002-06-27 | Abbott Lab | Biaril sulfonamidas son utiles como inhibidores de proliferacion celular |
US6797820B2 (en) | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023342A (en) * | 1988-05-26 | 1991-06-11 | Massachusetts Institute Of Technology | Cyclic sulfate compounds |
JP2753871B2 (ja) * | 1989-10-19 | 1998-05-20 | 三菱化学株式会社 | 有機高分子液晶薄膜及び情報記録方法 |
JPH03266819A (ja) * | 1990-03-16 | 1991-11-27 | Fuji Electric Co Ltd | 非線形光学材料 |
CA2115183A1 (en) * | 1993-02-12 | 1994-08-13 | Takashi Nomoto | Substituted amic acid derivatives |
-
1997
- 1997-12-26 AU AU53411/98A patent/AU5341198A/en not_active Abandoned
- 1997-12-26 BR BR9714087-2A patent/BR9714087A/pt not_active IP Right Cessation
- 1997-12-26 EP EP97950426A patent/EP0949238A1/en not_active Withdrawn
- 1997-12-26 ID IDW990590A patent/ID22281A/id unknown
- 1997-12-26 WO PCT/JP1997/004879 patent/WO1998029380A1/ja not_active Application Discontinuation
- 1997-12-26 CA CA002275603A patent/CA2275603A1/en not_active Abandoned
-
1999
- 1999-06-25 NO NO993171A patent/NO993171L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2275603A1 (en) | 1998-07-09 |
AU5341198A (en) | 1998-07-31 |
ID22281A (id) | 1999-09-30 |
NO993171D0 (no) | 1999-06-25 |
EP0949238A1 (en) | 1999-10-13 |
WO1998029380A1 (fr) | 1998-07-09 |
BR9714087A (pt) | 2000-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE227293T1 (de) | 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one | |
DE69919334D1 (de) | Phenylalaninderivate als inhibitoren von alpha4 integrinen | |
WO2003093250A3 (en) | Positive allosteric modulators of the nicotinic acetylcholine receptor | |
AU1463195A (en) | Substituted aromatic compounds as c.amp phosphodiesterase- and tnf-inhibitors | |
NO993868L (no) | 3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende samme | |
PT1158973E (pt) | Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos | |
LU91076I9 (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
CA2075173A1 (en) | Compounds and methods for inhibition of hiv and related viruses | |
CA2244785A1 (en) | Pentafluorobenzenesulfonamides and analogs | |
CA2301742A1 (en) | 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 | |
WO1996016079A3 (en) | Alpha-ketoamide derivatives as cathepsin l inhibitor | |
CA2233315A1 (en) | Pharmaceutical compositions containing hydroximic acid derivatives | |
CA2238845A1 (fr) | Nouveaux derives de 2,3,5-trimethyl-4-hydroxy anilides, leur preparation et leur application en therapeutique | |
DE69635857D1 (de) | Pyrrolderivate und medizinische zubereitung. | |
NO984740L (no) | Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler | |
WO1992019211A3 (en) | Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same | |
NO993171L (no) | Substituerte propionylderivater | |
CA2150546A1 (en) | Agent for inhibiting production of interleukin-8 | |
AU1398797A (en) | 3-(bis-substituted-phenylmethylene)oxindole derivatives | |
NO980788L (no) | Immunosuppressant | |
DK1025101T3 (da) | Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet | |
WO1998029407A3 (en) | N-(pyridinylamino)isoindolines for treating alzheimer's and depression | |
JPS5643264A (en) | 1-oxoisoindoline derivative and preventive for plant disease containing the same as the effective component | |
DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
CA2208032A1 (en) | Substituted amidinonaphthyl ester derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |